Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $558.06 million. The enterprise value is -$144.07 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KROS has 40.62 million shares outstanding. The number of shares has increased by 23.97% in one year.
Current Share Class | 40.62M |
Shares Outstanding | 40.62M |
Shares Change (YoY) | +23.97% |
Shares Change (QoQ) | +1.69% |
Owned by Insiders (%) | 1.07% |
Owned by Institutions (%) | 82.92% |
Float | 30.75M |
Valuation Ratios
The trailing PE ratio is 126.10.
PE Ratio | 126.10 |
Forward PE | n/a |
PS Ratio | 2.47 |
Forward PS | n/a |
PB Ratio | 0.76 |
P/TBV Ratio | 0.77 |
P/FCF Ratio | 12.88 |
P/OCF Ratio | 12.44 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.29, with a Debt / Equity ratio of 0.03.
Current Ratio | 19.29 |
Quick Ratio | 18.79 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | 0.43 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.71% and return on invested capital (ROIC) is -1.06%.
Return on Equity (ROE) | 0.71% |
Return on Assets (ROA) | -1.01% |
Return on Invested Capital (ROIC) | -1.06% |
Return on Capital Employed (ROCE) | -1.38% |
Revenue Per Employee | $1.27M |
Profits Per Employee | $24,923 |
Employee Count | 169 |
Asset Turnover | 0.34 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KROS has paid $10.34 million in taxes.
Income Tax | 10.34M |
Effective Tax Rate | 71.06% |
Stock Price Statistics
The stock price has decreased by -74.68% in the last 52 weeks. The beta is 1.33, so KROS's price volatility has been higher than the market average.
Beta (5Y) | 1.33 |
52-Week Price Change | -74.68% |
50-Day Moving Average | 12.25 |
200-Day Moving Average | 33.84 |
Relative Strength Index (RSI) | 55.11 |
Average Volume (20 Days) | 1,035,197 |
Short Selling Information
The latest short interest is 5.27 million, so 12.97% of the outstanding shares have been sold short.
Short Interest | 5.27M |
Short Previous Month | 4.41M |
Short % of Shares Out | 12.97% |
Short % of Float | 17.13% |
Short Ratio (days to cover) | 3.45 |
Income Statement
In the last 12 months, KROS had revenue of $214.71 million and earned $4.21 million in profits. Earnings per share was $0.11.
Revenue | 214.71M |
Gross Profit | 204.26M |
Operating Income | -10.31M |
Pretax Income | -168.05M |
Net Income | 4.21M |
EBITDA | -9.01M |
EBIT | -10.31M |
Earnings Per Share (EPS) | $0.11 |
Full Income Statement Balance Sheet
The company has $720.54 million in cash and $18.41 million in debt, giving a net cash position of $702.13 million or $17.29 per share.
Cash & Cash Equivalents | 720.54M |
Total Debt | 18.41M |
Net Cash | 702.13M |
Net Cash Per Share | $17.29 |
Equity (Book Value) | 728.87M |
Book Value Per Share | 17.97 |
Working Capital | 720.13M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $44.86 million and capital expenditures -$1.55 million, giving a free cash flow of $43.31 million.
Operating Cash Flow | 44.86M |
Capital Expenditures | -1.55M |
Free Cash Flow | 43.31M |
FCF Per Share | $1.07 |
Full Cash Flow Statement Margins
Gross margin is 95.13%, with operating and profit margins of -4.80% and 1.96%.
Gross Margin | 95.13% |
Operating Margin | -4.80% |
Pretax Margin | 6.78% |
Profit Margin | 1.96% |
EBITDA Margin | -4.20% |
EBIT Margin | -4.80% |
FCF Margin | 20.17% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.97% |
Shareholder Yield | -23.97% |
Earnings Yield | 0.75% |
FCF Yield | 7.76% |
Dividend Details Analyst Forecast
The average price target for KROS is $21.00, which is 52.84% higher than the current price. The consensus rating is "Buy".
Price Target | $21.00 |
Price Target Difference | 52.84% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 103.55% |
EPS Growth Forecast (5Y) | -15.97% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 17.63 and a Piotroski F-Score of 5.
Altman Z-Score | 17.63 |
Piotroski F-Score | 5 |